Oncology Phase 1 Trials
White Paper
This IQVIA White Paper provides a comprehensive scientific review of Phase I trials in oncology, and highlights best practices and operational recommendations for their successful delivery. Early-phase studies, which introduce an investigational new drug into human subjects, represent a challenging first step in a new drug’s clinical development program. They are the bridge between basic science and clinical development, and provide pivotal information to select the right drug at the right dose for the right patients to be investigated in the subsequent phases of clinical development.
Contact Us
Contact Us

Email Us

Interested in learning more about how IQVIA can create solutions to help you drive healthcare forward?

Call Us

We're available during standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.